Damaged LSECs release vascular endothelial growth factor (VEGF) and angiopoietin-2 (ANGPT2), increasing vascular permeability and providing a physical pathway for circulating tumor cells (CTCs) to extravasate (27), thereby promoting intrahepatic metastasis and early recurrence. The gene discussed is VEGFA; the disease is neoplasm.